James Bond´s nemesis in the most recent film likely failed neuroanatomy, said real-life neurosurgeon and scientist Dr. Michael Cusimano of St. Michael´s Hospital.
The out-of-hospital birth setting in Oregon was associated with a higher risk of perinatal death, while the in-hospital birth setting was associated with a higher risk for cesarean delivery and other obstetric interventions (e.g., induction or augmentation of labor), according a study published today in the New England Journal of Medicine by researchers at Oregon Health & Science University.
Using mice whose front paws were still partly disabled after an initial induced stroke, Johns Hopkins researchers report that inducing a second stroke nearby in their brains let them “rehab” the animals to successfully grab food pellets with those paws at pre-stroke efficiency.
New Haven Pharmaceuticals, Inc. today announced the availability by prescription of DURLAZA™, the first and only 24-hour, extended-release aspirin capsules (162.5mg) approved by the U.S. Food and Drug Administration (FDA) for the secondary prevention of stroke and acute cardiac events, including myocardial infarction (heart attack) in high-risk cardiovascular patients. DURLAZA is now commercially available for physicians and their patients
Scientists at VIB and KU Leuven have identified the oxygen sensor PHD1 as a potential target for the treatment of brain infarction (ischemic stroke). Despite (minor) improvements in stroke treatment, stroke remains the fourth leading cause of death and the most common reason of severe disability. The impact of stroke is overwhelming for the patient, family and society -representing one of the largest unmet medical needs. Research led by prof. Peter Carmeliet and dr. Annelies Quaegebeur (VIB/KU Leuven) indicates that inhibition of PHD1 offers protection against stroke, via an unexpected mechanism, raising hope for future stroke treatment. The study was published in the leading medical journal Cell Metabolism.
A UT Southwestern Medical Center study to evaluate nursing protocols designed to better triage and treat stroke patients using telemedicine will be the first study using a new consortium of medical centers.
Researchers stress the need for early occlusion of subarachnoid aneurysms to prevent death from rebleeding.
Researchers at the University of Arizona have invented a device that for the first time allows neurosurgeons, who use microscopes extensively while operating, to see blood flowing inside vessels and more clearly distinguish cancerous from healthy tissue under the microscope.
November 6, 2014—Lazarus Effect, Inc. announced that the company’s Lazarus Cover accessory device has received European CE Mark approval. The device is a nitinol mesh cover that surrounds a retriever device and captured material during removal from a blood vessel. Lazarus Effect plans to launch the Lazarus Cover in Europe during the first quarter of 2015.
November 4, 2014—VIVA Physicians, Inc. announced that Christopher J. Kwolek, MD, presented findings from the ROADSTER pivotal trial during a late-breaking trials session at the VIVA 2014: Vascular InterVentional Advances meeting in Las Vegas, Nevada. ROADSTER is a prospective, multicenter, investigational device exemption study designed to evaluate the safety and effectiveness of a novel hybrid carotid revascularization procedure using Silk Road Medical, Inc.’s Enroute transcarotid neuroprotection system (NPS).
The United States Preventive Services Task Force recommends against screening for asymptomatic carotid artery stenosis in the general adult population, according to a recommendation statement being published in Annals of Internal Medicine.
Larry Ambrose was diagnosed as having a stroke a few days after he woke up one night, wandered into his kitchen and couldn´t read the time on his microwave. Ambrose, like 25 percent of all stroke patients, experienced a cryptogenic ischemic stroke, meaning physicians were unable to determine a cause.
In a new study published online in the Journal of the American Heart Association, researchers at Columbia Engineering report that they have identified a new component of the biological mechanism that controls blood flow in the brain. Led by Elizabeth M. C. Hillman, associate professor of biomedical engineering, the team has demonstrated, for the first time, that the vascular endothelium plays a critical role in the regulation of blood flow in response to stimulation in the living brain.
A new or recurrent stroke occurs in around 795,000 Americans every year and causes approximately 137,000 deaths. But new research published in the journal Neurology suggests a diet higher in protein may reduce stroke risk.
June 11, 2014—Covidien announced US Food and Drug Administration (FDA) approval of its Apollo Onyx delivery microcatheter. The detachable-tip microcatheter is designed to mitigate the technical challenges of catheter retrieval during Onyx liquid embolic system (LES) embolizations of brain arteriovenous malformations (bAVMs).
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos